Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
Anthropic today updated its Sonnet model to version 4.6, and the company says it is the most capable Sonnet model to date with upgrades across coding, computer use, long-context reasoning, agent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results